Do BMED and WDNA hold the same stocks?

By their latest filings, 25% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BMED or WDNA?

BMED has 62% of its weight in S&P 500 names and WDNA has 26%, so BMED differs more from the index.

Which is cheaper, BMED or WDNA?

BMED charges 0.55% a year and WDNA charges 0.45%, so WDNA is cheaper. Fees come from each fund's prospectus.

Share on X Download as PDF Open live

BMED vs WDNA: which is really different?

BMED and WDNA hold 25% of their weight in the same names, and WDNA returned +58.6% over the year. iShares Health Innovation Active ETF and WisdomTree BioRevolution Fund.

61.5%

BMED in the S&P 500

25.9%

WDNA in the S&P 500

+29.3%

BMED total return, 1 year

+58.6%

WDNA total return, 1 year

BMED · 1 year to Sep 30, 202639% of its weight is outside the S&P 500

62% of BMED's weight is in S&P 500 companies and 39% is outside the index

WDNA · 1 year to Sep 30, 202674% of its weight is outside the S&P 500

26% of WDNA's weight is in S&P 500 companies and 74% is outside the index

ETFIQ Off-Index Score · BMED scores higherHow much of it is not the index it is sold as an alternative to?

BMED 35.2

WDNA 34

0.1, the lowest in this set92.0, the highest

A percentile among the 375 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it → How it is computed →

What they hold in common

By the books each fund has filed, BMED and WDNA hold 25% of their money in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and Sep 30, 2026.

50%

half

25% in common

Positions both hold, largest shared weight first

Holding BMED WDNA

MODERNA 5.19% 4.15%

JOHNSON & JOHNSON 4.17% 2.97%

TEMPUS AI CLASS A 1.57% 2.29%

AMGEN INC 2.45% 1.54%

THERMO FISHER SCIENTIFIC INC 4.41% 1.52%

GILEAD SCIENCES 5.00% 1.51%

ROIVANT SCIENCES LTD 1.37% 1.73%

PFIZER 1.52% 1.35%

VERTEX PHARMACEUTICALS 3.35% 1.34%

NOVARTIS AG 1.83% 1.33%

ARGENX SE ADR 1.92% 0.94%

PROTAGONIST THERAPEUTICS 0.88% 1.03%

Only in BMED

ABBVIE 4.61%

IQVIA HOLDINGS 3.75%

WATERS CORP 3.66%

METTLER TOLEDO 3.33%

EDWARDS LIFESCIENCES 2.96%

ROCHE PS PAR AG 2.58%

DEXCOM INC 2.43%

INCYTE CORP 2.31%

Only in WDNA

TWIST BIOSCIENCE CORP 5.96%

ELI LILLY & COMPANY 4.08%

UNITED THERAPEUTICS CORP 2.45%

NATERA INC 2.33%

IMMUNOME INC 2.26%

STRUCTURE THERAPEUTICS INC 2.12%

STOKE THERAPEUTICS INC 2.10%

BEAM THERAPEUTICS INC 2.09%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed.

25% of the two portfolios are the same securities at the same weight.

Performance, window by window

	Total return		vs the S&P 500		vs the Nasdaq-100
Window	BMED	WDNA	BMED	WDNA	BMED	WDNA
3 months	+12.6%	+16.6%	+10.1 pts	+14.1 pts	+10.5 pts	+14.5 pts
6 months	+19.4%	+36.5%	+2.4 pts	+19.5 pts	−7.5 pts	+9.6 pts
1 year	+29.3%	+58.6%	+13.6 pts	+42.9 pts	+5.5 pts	+34.8 pts
3 years	+54.5%	+69.0%	−30.5 pts	−16.0 pts	−55.5 pts	−41.0 pts
Since launch BMED Oct 2020 · WDNA Jun 2021	+35.9%	+2.8%	−109.5 pts	−93.2 pts	−135.6 pts	−128.7 pts

BMED and WDNA over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ. Open the live comparison on ETFIQ →

On the same fields

BMED

iShares Health Innovation Active ETF · Holds 60 stocks in healthcare innovation and GLP-1, 62% of its weight in S&P 500 companies

WDNA

WisdomTree BioRevolution Fund · Holds 80 stocks in healthcare innovation and GLP-1, 26% of its weight in S&P 500 companies

Issuer iShares WisdomTree

Theme Healthcare innovation and GLP-1 Healthcare innovation and GLP-1

In the S&P 500 61.5% 25.9%

Active share vs the S&P 500 95.6% 95.3%

In the Nasdaq-100 13.2% 5.8%

Holdings 60 80

Top ten, share of the fund 42.9% 30.7%

Expense ratio 0.55% 0.45%

Fee for the differing part 0.58% 0.47%

Total return, 1 year +29.3% +58.6%

vs the S&P 500 +13.6 pts +42.9 pts

vs the Nasdaq-100 +5.5 pts +34.8 pts

Below its high −1.0% −8.1%

Net assets $14m $4m

BMED and WDNA on the same fields, as of Sep 30, 2026. Source: ETFIQ.

BMED in plain words

By weight, 62% of BMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 43% of the fund across 60 positions, as published by its issuer for Sep 30, 2026. Over the year to Sep 30, 2026 the fund returned +29.3% with distributions reinvested against +15.7% for the S&P 500, so a holder was ahead by 13.6 pts.

WDNA in plain words

By weight, 26% of WDNA's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 31% of the fund across 80 positions, as filed for Jun 30, 2026. Over the year to Sep 30, 2026 the fund returned +58.6% with distributions reinvested against +15.7% for the S&P 500, so a holder was ahead by 42.9 pts. It sits 8.1% below its all-time high of Sep 2, 2021.

Questions people ask

Do BMED and WDNA hold the same stocks?: By their latest filings, 25% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BMED or WDNA?: BMED has 62% of its weight in S&P 500 names and WDNA has 26%, so BMED differs more from the index.
Which is cheaper, BMED or WDNA?: BMED charges 0.55% a year and WDNA charges 0.45%, so WDNA is cheaper. Fees come from each fund's prospectus.

Other comparisons

BMED vs THNR BMED vs EKG BMED vs HEAL BMED vs HELX WDNA vs EKG WDNA vs HEAL WDNA vs HELX WDNA vs LGHT

BMED on its own →WDNA on its own →How every figure is computed →Standards and sources →

Where these figures came from

BMED filings on SEC EDGAR ↗BMED prospectus with the expense ratio (SEC) ↗iShares page for BMED ↗WDNA filings on SEC EDGAR ↗WDNA prospectus with the expense ratio (SEC) ↗WisdomTree page for WDNA ↗

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement. A comparison is not a recommendation.

Cite this page

ETFIQ, BMED against WDNA, data as of Sep 30, 2026. https://etfiq.com/compare/themes/bmed-vs-wdna

Open data

Free to use with attribution. Every figure is calculated from a named public source; the method is at etfiq.com/methodology.